Mediatum Names Industrial Practice Leader

February 26, 2016 – Executive recruiter Mediatum International has added Johannes Suciu to its new office in Frankfurt, Germany as senior client partner. He becomes head of the firm’s chemical & industrial practice group and will assist clients in senior level recruitment.

Mr. Suciu joins Marijana Pavlovic, who joined the firm in November, to make up the office’s industrial executive search team. Ms. Pavlovic was previously a senior associate with DHR International.

Prior to joining Mediatum, Mr. Suciu served as executive vice president of DHR where he executed senior assignments in the industrial and life science sectors. Before that, he was a consultant with Korn Ferry’s Futurestep. Prior to entering the executive search field, he worked for a consulting boutique where he was responsible for HR assessment, training and development for clients within the real estate and automotive industries.

“With his strong track record of growing new business in the industrial and chemical industry, Johannes is the right choice to lead the execution of our long-term global strategy and the further expansion of our business,” said Thomas Winter, managing director of Mediatum Germany.

Our Latest Thinking
Hunt Scanlon’s global staffing intelligence data comes in many forms. Here you can access dozens of thought-provoking and insightful news items from our flagship human capital archives.

Get Info

Germany is the largest national economy in Europe, the fourth-largest by nominal GDP in the world. Well-known companies in the country include Mercedes-Benz, BMW, SAP, Siemens, Volkswagen, Adidas, Audi, Allianz, Porsche, Bayer, BASF, Bosch, and Nivea.

Founded in 2001, Mediatum International focuses on the chemical and life sciences sectors as well as a number of specialized related areas. Its international network of offices can be found in Basel, Boston, Heidelberg, London, Munich, Philadelphia, Warsaw and Vienna. Mediatum generally focuses its expertise in pharmaceuticals, biotechnology, diagnostics, medical technology, healthcare, chemicals, research, public institutions, venture capital businesses and startups.

Contributed by Dale M. Zupsansky, Managing Editor, Hunt Scanlon Media

Share This Article


Notify of
Inline Feedbacks
View all comments